The leaders of AMN Healthcare Services Inc. plan to ramp up their acquisition activity now that both the staffing market and the company’s finances are in better shape than a few years ago.
Dallas-based AMN during the second quarter spent $3 million to buy two companies, real-time interpretation and translation venture Jaide Health and search-focused Essential Leadership Assessment. Speaking on her team’s second-quarter earnings call Aug. 7, President and CEO Cary Grace said those deals have already started to pay dividends in terms of customer deals.
Speaking more broadly to the state of the market, Grace said AMN is “seeing increasing indications of industry consolidation” as the staffing market recovers from a massive post-pandemic slump, a trend she discussed early this year. More potential deals have been bubbling up this year
CFO and COO Brian Scott expanded on that idea by noting that AMN leaders have paid down a good chunk of its debt in recent quarters and are now “in a position to be more active” as possible acquisitions land on their desks.
“You can imagine we’ve got a pretty strong filter of anything that we would want to consider bringing in,” Scott said on the conference call. “But we’re in a position now that if the right opportunity comes along [and if] we think it would be accretive, then we can participate more actively than we might have been able to 12 or 24 months ago.”
AMN rang up a net profit of $21.2 million on revenues of $673 million during the second quarter, the bottom-line number being a big improvement from a loss of $116 million in the same period of 2025. Grace told analysts on Aug. 7 that her team saw gains across the company’s books of business this spring – which corresponds to Staffing Industry Analysts saying that healthcare staffing firms’ aggregate revenues in June rose 6 percent year over year, which was the fastest pace since October of 2022.
“We’ve really been in the kind of year-over-year demand increase posture for allied [professionals] for most of 2025 and ’26,” Grace said. “But what we saw in nurse [work] that accelerated in May was broad-based.”
Shares of AMN (Ticker: AMN) jumped about 20 percent to $36 after the Q2 report and conference call commentary. They have, however, since given up two-thirds of that pop and finished trading Aug. 12 at $32.44. After sliding as the pandemic receded, the stock has now more than doubled year to date, regrowing AMN’s market value to about $1.3 billion.